Tpharm.info


Zolpidem tar 6.25





RxNORM - Zolpidem tartrate 6.25 MG Ambien - Classes NCBO

10/18/2014
08:36 | Author: Lauren Ross

Zolpidem tar er
RxNORM - Zolpidem tartrate 6.25 MG Ambien - Classes NCBO

Preferred Name. Zolpidem tartrate 6.25 MG [Ambien]. ID. http://purl.bioontology.org/ontology/RXNORM/854895. constitutes.

Zolpidem tartrate 6.25 MG 2977595 854895 http://purl.bioontology.org/ontology/RXNORM/854893 T200.

Zolpidem tartrate 6.25 MG http://purl.bioontology.org/ontology/RXNORM/854895 http://purl.bioontology.org/ontology/RXNORM/854896 C2709718 http://purl.bioontology.org/ontology/RXNORM/131725 http://purl.bioontology.org/ontology/STY/T200 854895.

Comments (0)



Generic Ambien CR 6.25mg (Zolpidem tartrate) Launched - ScripNet

12/17/2014
06:12 | Author: David Perry

Zolpidem tar er
Generic Ambien CR 6.25mg (Zolpidem tartrate) Launched - ScripNet

October 13, 2010 - Actavis Elizabeth LLC received final FDA approval and launched their generic equivalent of Sanofi-Aventis' Ambien CR tablets. Actavis.

Zolpidem CR is indicated for the short-term treatment of insomnia involving difficulty with sleep onset and maintenance. In elderly, debilitated or hepatically impaired patients, or in patients with hepatic insufficiency or dysfunction, the recommended dose of Zolpidem CR is 6.25 mg. These patients should be closely monitored. Zolpidem CR has a rapid onset and lasting action and should be taken immediay before bedtime when a full 8 hours can be dedicated to sleep. The tablet should not be taken with a meal, and should not be chewed or crushed; it should be swallowed whole.

October 13, 2010 - Actavis Elizabeth LLC received final FDA approval and launched their generic equivalent of Sanofi-Aventis’ Ambien CR tablets. Actavis attained approval for the 6.25mg strength in the 100 count size. They are in the process of finalizing their official press release at this time, although the product is already available at wholesalers.

Search.

Side effects can include a worsening of depression, complex sleep behaviors (i.e. sleep walking, eating or driving), lingering drowsiness into the next day and altered taste sensations. Insomnia should be re-evaluated if it persists after 7-10 days of taking Zolpidem CR. Chronic use of sleep medications may be habit forming. Potential drug interactions may occur when Zolpidem CR is taken in conjunction with other central nervous system depressants (including alcohol), Chlorpromazine, Rifampin and Ketoconozole.

For more information, please contact Actavis at (973).

2011 ScripNet, Inc.

Comments (0)